DiaMedica Therapeutics Inc. (DMAC) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning, ladies and gentlemen, and welcome to the Diametica Therapeutics first quarter 2025 conference call. An audio recording of the webcast will be available shortly after the call today on Diametica's website at www.diametica.com in the investor relations section. Before Diametica proceeds with its remarks, please note that the company will be making forward-looking statements on today's call. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected in these statements. More information, including factors that could cause actual results to differ from projected results, appears in the section entitled Cautionary Note Regarding Forward-Looking Statements in the company's press release issued yesterday and under the heading Risk Factors in the company's most recent annual report on Form 10-K, and most recent quarterly report, Form 10-Q. Diametica's SEC filings are available on the SEC's website, www.sec.gov, and on its website, diametica.com. Please also note that any comments made on today's call speak only as of today, May 14, 2025, and may no longer be accurate at the time of any replay or transcript rereading. Diomedica disclaims any duty to update its forward-looking statements. Following the prepared remarks, the phone lines will be open for questions. I would now like to turn you over to your host for today's call, Mr. Rick Pauls, Diomedica's president and chief executive officer. Mr. Pauls? Thank you, operator. Hello, everyone, and welcome to our first quarter 2025 conference call. I am joined this morning by Scott Kellan, our chief financial officer. Dr. Lorianne Masioka is currently on short-term medical leave, and we hope she gets well soon. We're happy to be here today to upda...